Table 2.
Characteristic of the patients in terms of medication intake and disease activity in UC group
| UC | Number of patients | Disease activity based on CAI score | The extent of the disease | Duration of disease in months (mean duration and range) | Duration of therapy in months (mean duration and range) | |||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| < 4: remission | ≥ 4: active disease | ulcerative proctitis | left sided | extensive UC | ||||
| Without medication | 11 | 1 | 10 | 4 | 5 | 3 | 8 (1-24) | 6 (1-15) |
| 5-ASA | 11 | 8 | 3 | 4 | 4 | 3 | 36 (2- 56) | 32 (4-38) |
| Immunsuppressive therapy (cortisone, azathioprine, 6-MP) | 10 | 6 | 4 | 2 | 3 | 5 | 12 (2-46) | 8 (2-36) |
| Anti-TNF a | 1 | - | 1 | - | 1 | 6 | 1 | |